Revolutionizing Obesity & Cholesterol Treatment : The Power of Synthetic Thyroid Hormone via Nanogel Carriers

In the current global landscape, the prevalence of obesity is alarmingly high, affecting over 1 billion individuals. This condition signifies an excess accumulation of body fat, surpassing the healthy range recommended by medical standards in relation to one’s height and age. Alongside this, approximately 28.5 million people worldwide grapple with high cholesterol levels. This condition entails an elevated presence of cholesterol in the body, leading to its accumulation within the arteries and impeding proper blood flow.^(1,2)

Individuals who contend with obesity and/or high cholesterol face an elevated risk for a spectrum of other serious health conditions. These encompass cardiovascular disease, high blood pressure, diabetes, and even certain types of cancer. It is imperative to address these underlying health concerns to mitigate the potential risks associated with these conditions.

To deal with this multifaceted health challenge, researchers at the University of Massachusetts Amherst have pioneered a cutting-edge nanogel-based carrier system.⁽³⁾ This innovative platform is engineered to facilitate the targeted delivery of a drug that emulates synthetic thyroid hormone directly to the liver.⁽⁴⁾ Through meticulous experimentation in a mouse model, scientists have demonstrated that this liver-specific drug delivery system yielded remarkable results. Obese mice treated with this method experienced a notable reduction in weight, ultimately returning to a healthier range. Moreover, their cholesterol levels exhibited a marked decrease, signifying a promising therapeutic advancement in the battle against obesity and its associated complications.

The implications of this study, published in the esteemed journal PNAS NEXUS, hold tremendous potential for revolutionizing the approach to obesity management.⁽⁵⁾ This groundbreaking research not only underscores the significance of targeted drug delivery systems, but also underscores the critical role of innovative biomedical technologies in combating prevalent global health challenges. Read on to find out more about this. 

Before we move on to discuss the new research and its implications, it is important that we understand the exact role that the liver plays in our body, and how obesity and high cholesterol impacts the functioning of this highly important organ.

The liver is the largest solid organ in the human body. Remarkably versatile, it undertakes a wide array of functions, over 500 functions in fact, that are important for sustaining overall health.

Some of these functions include: 

• Filtering the blood, getting rid of waste products.
• Metabolizing toxins, including alcohol, rendering them less harmful.
• Producing bile, a vital agent in the digestion of food.⁽⁶⁾
• Orchestrating the metabolism of carbohydrates, fats, and proteins.
• Generating 80 percent of the body’s requisite cholesterol for essential physiological processes.
• Playing a pivotal role in blood sugar regulation.
• Serving as a repository for a variety of vitamins and minerals, including iron.
• Governing blood clotting mechanisms.⁽⁷⁾
• Safeguarding the body from potential infections.

The liver’s astonishing multitasking abilities has made it an indispensable guardian of our overall well-being.

Now, it is important to understand that there are several diseases that can harm the liver, thus impacting the entire body. Obesity and high cholesterol can both lead to fatty liver disease, inflammation, and scarring of the liver. High cholesterol can, in fact, worsen fatty liver disease and contribute to long-term liver damage. Conversely, liver inflammation from obesity may reduce bile production, leading to elevated cholesterol levels in the body.

A study from September 2022 revealed that elevated cholesterol levels not only exacerbate fatty liver disease, but can also contribute to more persistent liver scarring and dysfunction of immune cells.⁽⁸⁾ 

In this groundbreaking study, researchers at the University of Massachusetts Amherst engineered a nanogel-based carrier system tailored for targeted drug delivery directly to the liver. The researchers placed significant importance on the nanogels’ inherent affinity for the liver, which should prove to be especially important for metabolic disorders.^(9,10) To enhance the precision, the nanogels were augmented with specific chemical functionalities, ensuring preferential homing to the liver and subsequent uptake by hepatocytes.⁽¹¹⁾

The drug of choice in this study was a thyromimetic, designed to emulate synthetic thyroid hormone.⁽¹²⁾ The research team explained that this drug primarily targets the thyroid hormone receptor beta, which is prominently present in the liver.⁽¹³⁾ Activation of this receptor induces various physiological responses, including fatty acid oxidation and reverse cholesterol pathway, which is believed to account for the observed weight reduction and cholesterol level decrease.^(14,15) However, further research is still needed to validate this hypothesis.

Previous investigations have explored thyroid hormone mimics as agents for lowering cholesterol and are currently undergoing clinical trials for treating nonalcoholic steatohepatitis (NASH).⁽¹⁶⁾ Yet, historical challenges included limited drug bioavailability and potential off-target effects on other organs. The thyromimetics in clinical trials for NASH have displayed low potency, thereby not fully harnessing the drug’s potential.⁽¹⁷⁾

The research team’s innovative approach combined a potent thyromimetic with the nanogel, effectively mitigating toxicity concerns associated with systemic exposure while concentrating the drug precisely at the intended site. 

In this study, the research team conducted a carefully designed experiment using two groups of mice to look at the effectiveness of the thyromimetic drug delivered through the nanogel-based carrier. One group was subjected to a high-fat, high-sugar, high-cholesterol diet for a period of ten weeks, resulting in a doubling of their body weight. On the other hand, a control group was fed a balanced, healthy diet over the same duration.

The obese mice received daily intraperitoneal injections of the thyromimetic drug encapsulated within the nanogel carrier for a span of five weeks. At the end of this period, researchers observed a remarkable transformation in the mice with obesity. Despite continuing their high-fat diet, these mice had reverted back to their initial weight. Furthermore, the mice administered the drug exhibited significant reductions in their cholesterol levels, coupled with notable improvements in liver inflammation.

The research team expressed confidence in the anticipated metabolic benefits of the intervention, such as cholesterol reduction and the amelioration of fatty liver. However, the team was also equally taken aback, but elated, to see the substantial impact on body weight reduction. It is worth noting that while thyroid hormone mimics typically induce weight loss, they often come with some accompanying side effects.⁽¹⁸⁾ Strikingly, no adverse effects were observed with the administered drug, suggesting its potential as a safe and efficacious therapeutic approach. 

Upon reviewing this study, experts have expressed a mix of enthusiasm and prudence, underlining that this is an early-phase study. There is no doubt that a well-established understanding of obesity and high cholesterol will come in handy to assess many other risk factors for a spectrum of cardiovascular diseases. It is important to remember that the complexity of these conditions often need multifaceted management approaches encompassing lifestyle adjustments, dietary modifications, physical activity, and in many instances, pharmacological interventions.

The noteworthy aspect of this study lies in its innovative approach, honing in on optimizing the functionality of a specific organ. The groundbreaking potential of employing nanogel-based drug delivery to target the liver with thyromimetic, if successful, could represent a significant stride in medical advancement.

Despite the compelling nature of the results, several experts have sounded a note of caution, highlighting the substantial journey from these preclinical findings to the initiation of human clinical trials. The study is still in the nascent stages and there is a need for multiple crucial steps to seamlessly come together before drawing any conclusions. 

Maintaining a healthy liver is crucial for overall well-being, as it performs numerous vital functions in the body. Here are some tips that will help promote liver health: 

• Have a Balanced Diet: Prioritize a well-rounded diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats.
• Moderate Alcohol Consumption: If you choose to consume alcohol, do so in moderation. For example, limit to one drink per day for women and two for men.
• Maintain a Healthy Weight: Aim for a healthy body weight through a combination of regular exercise and a balanced diet. This helps prevent fatty liver disease.
• Exercise Regularly: Engage in regular physical activity to improve overall health and support liver function. Aim for at least 150 minutes of moderate exercise per week.
• Limit Processed Foods and Sugars: Minimize your intake of processed foods, sugary snacks, and sugary beverages, as they can contribute to liver fat accumulation.
• Monitor what Medications you take: Be cautious with over-the-counter and prescription medications. Some can be hard on the liver, especially in high doses or when combined with alcohol.
• Avoid Unprotected Sex and Sharing Needles: Hepatitis B and C can be transmitted through unprotected sex and sharing needles. Practice safe sex and avoid sharing needles to prevent liver infections.
• Limit your Exposure to Toxins: Minimize contact with chemicals and toxins at home and in the workplace. Use protective equipment when handling potentially harmful substances.
• Manage Chronic Health Conditions: Effectively manage conditions like diabetes, high blood pressure, and high cholesterol, as they can contribute to liver problems.
• Avoid Taking Excessive Supplements: While some supplements can benefit liver health, excessive doses can be harmful. Consult a healthcare provider before starting any new supplements.

By incorporating these tips into your lifestyle, you can significantly contribute to maintaining a healthy liver and overall well-being. 

The groundbreaking research on synthetic thyroid hormone delivery through nanogel-based carriers represents a significant stride in the fields of cholesterol management and obesity treatment. The innovative approach of targeting the liver directly has shown promising results in reducing weight and cholesterol levels in preclinical studies. While the transition to human clinical trials is still a substantial undertaking, the potential benefits of this approach are important. If successful, this could revolutionize the way we address these prevalent health challenges, offering new hope for individuals struggling with obesity and high cholesterol.

References: